Literature DB >> 31304922

[Expression of PROK 1 and its receptor PROKR 1 in endometriosis and its clinical significance].

Yahong Wu1, Xianqing Wu1.   

Abstract

OBJECTIVE: To investigate the role of prokineticin (PROK) 1 and prokineticin-receptor (PROKR) 1 in the pathogenesis of endometriosis and its clinical signifaicance.

Methods: Quantitative real-time PCR (qPCR) and Western bloting were used to detect the expression of PROK 1 and PROKR 1 in eutopic and ectopic endometrium of endometriosis (n=22) and normal control endometrium (n=18). Endometrial stromal cells were isolated and cultured in 6 normal controls. The expression of PROK 1 mRNA was detected by qPCR after treated with estradiol (E2) or TNF-α.

Results: PROK 1 and PROKR 1 mRNA were expressed in eutopic and ectopic endometrium of endometriosis and normal control endometrium, and the expression level gradually declined (P<0.05). The expression of PROKR-1 protein in eutopic and ectopic endometrium of endometriosis and normal control endometrium gradually declined (P<0.05). The expression of PROK-1 protein in normal control endometrial cells and eutopic endometrium cell was higher in secretory phase than in proliferative phase (P<0. 05). E2 did not change the expression of PROK 1, whereas TNF-α up-regulated the expression of PROK 1.

Conclusion: PROK-1 and its receptors are involved in the pathogenesis and development of endometriosis. TNF-α can promote angiogenesis via up-regulating the expression of PROK 1.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31304922     DOI: 10.11817/j.issn.1672-7347.2019.06.003

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  2 in total

1.  A Comparative Study of Endometriosis and Normal Endometrium Based on Ultrasound Observation.

Authors:  Lin Jiao; Jue Wang; Lingling Zhu
Journal:  Appl Bionics Biomech       Date:  2022-04-30       Impact factor: 1.664

Review 2.  Molecular Mechanisms Underlying the Association between Endometriosis and Ectopic Pregnancy.

Authors:  Julia Załęcka; Katarzyna Pankiewicz; Tadeusz Issat; Piotr Laudański
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.